NCT02562326 - A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes Mellitus | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

BioChaperone insulin lispro

Injection immediately before the start of the individualised standard meal

DRUG

Humalog®

Injection immediately before the start of the individualised standard meal

Trial Locations (2)

Profil GmbH, Neuss

Profil Mainz GmbH & Co.KG, Mainz